Literature DB >> 10673321

Nicotinic acetylcholine receptor agonists promote survival and reduce apoptosis of chick ciliary ganglion neurons.

P C Pugh1, J F Margiotta.   

Abstract

The abundance, diversity, and ubiquitous expression of neuronal nicotinic acetylcholine receptors (AChRs) suggest that many are involved in functions other than synaptic transmission. We now report that a major AChR class promotes neuronal survival. The 10-day survival of ciliary ganglion neurons in basal culture medium (MEM) was approximately 35%, but increased to approximately 75% in MEM containing nicotine (MEM/Nic) or carbachol, an effect similar to that achieved by chronic depolarization with KCl. Pharmacological experiments revealed that agonist-enhanced survival requires activation of AChRs sensitive to alpha-bungarotoxin (alphaBgt). alphaBgt-AChRs partly support neuronal survival by limiting apoptosis since fewer apoptotic neurons were observed in MEM/Nic compared to MEM. Moreover, nicotinic survival support was not further enhanced by fibroblast growth factor, as seen for KCl, but increased to 100% by adding PACAP, a trophic neuropeptide present in the ganglion. These results indicate that alphaBgt-AChR activation regulates neuronal survival and suggest a mechanism involving reduced apoptosis and interaction with an endogenous neuropeptide growth factor. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673321     DOI: 10.1006/mcne.1999.0810

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  15 in total

1.  Extrasynaptic alpha 7-nicotinic acetylcholine receptor expression in developing neurons is regulated by inputs, targets, and activity.

Authors:  Craig L Brumwell; James L Johnson; Michele H Jacob
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

2.  Requirement of nicotinic acetylcholine receptor subunit beta2 in the maintenance of spiral ganglion neurons during aging.

Authors:  Jianxin Bao; Debin Lei; Yafei Du; Kevin K Ohlemiller; Arthur L Beaudet; Lorna W Role
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

Review 3.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Active Sleep Promotes Coherent Oscillatory Activity in the Cortico-Hippocampal System of Infant Rats.

Authors:  Carlos Del Rio-Bermudez; Jangjin Kim; Greta Sokoloff; Mark S Blumberg
Journal:  Cereb Cortex       Date:  2020-04-14       Impact factor: 5.357

5.  Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.

Authors:  Maryka Quik; Li Chen; Neeraja Parameswaran; Xinmin Xie; J William Langston; Sarah E McCallum
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

6.  The long-term effects of prenatal nicotine exposure on neurologic development.

Authors:  Jane Blood-Siegfried; Elizabeth K Rende
Journal:  J Midwifery Womens Health       Date:  2010 Mar-Apr       Impact factor: 2.388

7.  PACAP/PAC1R signaling modulates acetylcholine release at neuronal nicotinic synapses.

Authors:  Phyllis C Pugh; Selwyn S Jayakar; Joseph F Margiotta
Journal:  Mol Cell Neurosci       Date:  2009-12-01       Impact factor: 4.314

8.  Cell-autonomous inhibition of alpha 7-containing nicotinic acetylcholine receptors prevents death of parasympathetic neurons during development.

Authors:  Martin Hruska; Rae Nishi
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

9.  Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.

Authors:  Geeta Sharma; Sukumar Vijayaraghavan
Journal:  Subst Abuse       Date:  2008-11-11

10.  Prostate stem cell antigen is an endogenous lynx1-like prototoxin that antagonizes alpha7-containing nicotinic receptors and prevents programmed cell death of parasympathetic neurons.

Authors:  Martin Hruska; Julie Keefe; David Wert; Ayse Begum Tekinay; Jonathan J Hulce; Ines Ibañez-Tallon; Rae Nishi
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.